While cannabinoids offer a potential alternative for refractory chronic pain, optimal use requires personalized dosing and ...
The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.
SOUTH SAN FRANCISCO, Calif. - Vistagen Therapeutics (VTGN), a clinical-stage biopharmaceutical company with a market ...
Among patients with chronic insomnia, transcutaneous auricular vagus nerve stimulation improves sleep quality and is safe and effective.
Botox shots have increased in recent years, not just for cosmetic purposes but also for medical applications. The therapy consists of a purified type of neurotoxin, produced by the bacterium ...
It may take up to two years for Motassem to undergo the corrective surgeries he needs and to be fitted for a prosthetic. (ABC ...
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
Peeing shouldn't be painful-yet all too often it is. If you've found yourself wondering "Why does it burn when I pee?", ...